| Catalog No. | 
			TD-VK565196 | 
		
		
			| Species reactivity | 
			SARS-CoV-2 (2019-nCoV) | 
		
		
			| Applications | 
			Research Grade Biosimilar | 
		
		
			| Host species | 
			Human | 
		
		
			| Isotype | 
			IgG1, lambda2 | 
		
		
			| Expression system | 
			Mammalian Cells | 
		
		
			| Clonality | 
			Monoclonal | 
		
		
			| Target | 
			Spike glycoprotein, S glycoprotein, E2, Peplomer protein, Spike protein S1, Spike protein S2, Spike protein S2', S, 2, Receptor-Binding Domain, RBD | 
		
		
			| Endotoxin level | 
			Please contact the lab for this information. | 
		
		
			| Purity | 
			>95% purity as determined by SDS-PAGE. | 
		
		
			| Purification | 
			Protein A/G, purified from cell culture supernatant. | 
		
		
			| Accession | 
			P0DTC2-2 | 
		
		
			| Form | 
			Liquid | 
		
		
			| Storage buffer | 
			0.01M PBS,pH7.4. | 
		
		
			| Stability and Storage | 
			Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. | 
		
		
			| Alternate Names | 
			LY-CoV1404,LY3853113 | 
		
		
			| Background | 
			Bebtelovimab a humanized IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19. Bebtelovimab potently neutralizes SARS-CoV-2 variants, and inhibits COVID-19 with mild-to-moderate efficacy. | 
		
		
			| Note | 
			For research use only. Not for use in clinical or therapeutic applications. |